-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/please-help-find-something-to-ease-my-mothers-pain-with-restless-leg-syndrome-it-has-bothered-her-for-over-30-years-and-now-is-almost-unbearable-at-78-years-old-it-has-really-diminished-her-joy-in-life
January 06, 2010 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/is-there-an-easier-way-to-test-for-celiac-disease
March 11, 2012 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - We did not identify eligible trials of
antihistaminergic drugs or alcohol. … We have added text describe how specific drugs or
formulations can be used to target specific sleep … problems (Introduction: ‘Drugs can be specifically
formulated…’). … One of the most commonly
used drugs for insomnia. No evidence. … Drugs Aging. 2014 Oct;31(10):731-6.
doi: 10.1007/s40266-014-0211-3.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
February 01, 2016 - Medicines To Treat
Alcohol Use Disorder
A Review of the Research for Adults
Is This Information Right for Me?
Yes, this information is right for you if:
� Your doctor* said you have alcohol use disorder and need to stop
drinking or cut down the amount you drink.
� You have decided to stop or cut down your dri…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Pharmacotherapy for Adults With Alcohol Use
Disorder (AUD) in Outpatient Settings
Focus of This Summary
This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects
of medications in adults with alcohol use disorder (AUD). The systematic revi…
-
effectivehealthcare.ahrq.gov/system/files/docs/uv_light_covid-19-topic_brief.pdf
December 10, 2020 - idea that is being studied for COVID treatment, it is
currently investigational.1 The assessment of drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … drug
in some state Medicare drug plan formularies, which is the highest pricing tier for specialty
pharmaceuticals … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2014 Apr 10]. [5 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
December 01, 2015 - Prescription drugs are often used to treat insomnia. … We
found the most data on the newer FDA-approved drugs. … Results for adverse effects
varied across the different drugs and typically were not
different from … Drug trials
for certain drugs often used doses that are no longer
recommended by the FDA. … Drug Class Review:
Newer Drugs for Insomnia: Final Report Update 2 [Internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
November 01, 2022 - Medicare beneficiaries.1 Thus, CMS makes decisions
about providing insurance coverage for use of these drugs … For
studies that involve researching
the safety and effectiveness of
new drugs and biological
products … For studies that involve researching the safety and
effectiveness of new drugs and biological products … there may not be the extensive clinical trial record that is generated during
regulatory approval of pharmaceuticals … Specification for Cancer Drugs Fund data collection arrangements.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … The topic, buprenorphine implant (Probuphine™, Titan
Pharmaceuticals, Inc., South San Francisco, CA
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - observational studies presumed participants had
osteoporosis because of past fracture or use of
osteoporosis drugs … Food and Drug
Administration (FDA) approved osteoporosis
drugs, including risedronate, ibandronate, … Related Changes in Bone Turnover and Fracture Risk
Reduction in Clinical Trials of Anti‐Resorptive Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - observational studies presumed participants had
osteoporosis because of past fracture or use of
osteoporosis drugs … Food and Drug
Administration (FDA) approved osteoporosis
drugs, including risedronate, ibandronate, … Related Changes in Bone Turnover and Fracture Risk
Reduction in Clinical Trials of Anti‐Resorptive Drugs
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/comparative-effectiveness-for-the-treatment-of-major-depressive-disorder-mdd-key-questions-1-for-the-treatment-of-mdd-what-is-the-comparative-effectiveness-of-ssris-placebo-psychotherapy-exercise-and-alternative-therapies-2-f
March 11, 2013 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/products/phenylketonuria/research
February 22, 2012 - Data Sources
We searched MEDLINE, PsycINFO, Embase Drugs and Pharmacology, the Cumulative Index of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
January 01, 2009 - A number of drugs and dietary measures have been shown to reduce the rate of stone
recurrence.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
January 01, 2009 - corticosteroids, immune system suppressors,
antibiotics, anti-diarrheals, anti-tumor necrosis factor (TNF) drugs
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-best-options-for-fertility-treatment-in-terms-of-safety-and-effectiveness
January 31, 2013 - no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - longitudinal pro-
pensity score to compare outcomes between a new drug (exenatide)
and established drugs … We used our methods to estimate the effect
of the new versus established drugs on total health care charges … Additionally,
a separate, linkable file is available which includes pharmacy
claims for prescription drugs … May 2005 14,052 0.00 0.46 0.45
Emergency room visit June 2005 36 0.00 0.47 0.49
No. drugs June 2005 … This methodology has particular value for the study of
new drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
May 01, 2008 - Use of anti-dementia drugs was similar across settings,
with 24.7% of dementia cases in the community … larger than in the community,
but there is little difference in the proportions receiving anti-dementia drugs … In a previous study, the authors13 reviewed 81 recent randomized clinical trials of dementia
drugs … Our analysis of drugs typically used to treat behavioral manifestations of dementia found that
treatment … these utilization rates are not adjusted for potential
confounding factors, we cannot conclude the drugs
-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
April 12, 2018 - Drugs Used for Osteoporosis Treatment and Prevention
Drug class
Drug Name
Delivery Route
Dosing … Interventions
Drugs FDA approved for osteoporosis treatment or prevention (bisphosphonates, denosumab